DK0723777T3 - Tablet indeholdende enteriske granuler - Google Patents

Tablet indeholdende enteriske granuler

Info

Publication number: DK0723777T3
Authority: DK; Denmark
Prior art keywords: granules; tablet; enteric; tableting; reduced
Prior art date: 1993-10-12

Application number

DK94929012T

Other languages

Danish (da)

English (en)

Inventor

Tomohisa Matsushita

Mitsuo Hashimoto

Original Assignee

Mitsubishi Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-12

Filing date

1994-10-06

Publication date

2002-10-28

1994-10-06 Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp

2002-10-28 Application granted granted Critical

2002-10-28 Publication of DK0723777T3 publication Critical patent/DK0723777T3/da

Links

239000008187 granular material Substances 0.000 title abstract 7
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 abstract 1
229940024545 aluminum hydroxide Drugs 0.000 abstract 1
RJZNFXWQRHAVBP-UHFFFAOYSA-I aluminum;magnesium;pentahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Al+3] RJZNFXWQRHAVBP-UHFFFAOYSA-I 0.000 abstract 1
239000007931 coated granule Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 abstract 1
229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 abstract 1
239000000945 filler Substances 0.000 abstract 1
229960001545 hydrotalcite Drugs 0.000 abstract 1
229910001701 hydrotalcite Inorganic materials 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
235000017557 sodium bicarbonate Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK94929012T 1993-10-12 1994-10-06 Tablet indeholdende enteriske granuler DK0723777T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP25404993		1993-10-12
PCT/JP1994/001675 WO1995010264A1 (fr)	1993-10-12	1994-10-06	Tablette contenant des granules entero-solubles

Publications (1)

Publication Number	Publication Date
DK0723777T3 true DK0723777T3 (da)	2002-10-28

Family

ID=17259525

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94929012T DK0723777T3 (da)	1993-10-12	1994-10-06	Tablet indeholdende enteriske granuler

Country Status (12)

Country	Link
US (1)	US5798120A (de)
EP (1)	EP0723777B1 (de)
JP (1)	JP3710473B2 (de)
KR (1)	KR100353384B1 (de)
AT (1)	ATE219931T1 (de)
AU (1)	AU683092B2 (de)
CA (1)	CA2173506C (de)
DE (1)	DE69430921T2 (de)
DK (1)	DK0723777T3 (de)
ES (1)	ES2179079T3 (de)
PT (1)	PT723777E (de)
WO (1)	WO1995010264A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5817338A (en) *	1994-07-08	1998-10-06	Astra Aktiebolag	Multiple unit tableted dosage form of omeprazole
SE9402431D0 (sv) *	1994-07-08	1994-07-08	Astra Ab	New tablet formulation
SE9500422D0 (sv) *	1995-02-06	1995-02-06	Astra Ab	New oral pharmaceutical dosage forms
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en)	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6645988B2 (en)	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
SE9600071D0 (sv) †	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients I
SE512835C2 (sv) *	1996-01-08	2000-05-22	Astrazeneca Ab	Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE9600070D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
SE9600072D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients II
AU5446798A (en) *	1996-11-27	1998-06-22	Procter & Gamble Company, The	Compositions and methods for the treatment of gastrointestinal disorders
JP3870470B2 (ja) *	1997-02-07	2007-01-17	大正製薬株式会社	マルチプルユニットタイプ徐放性錠剤
US6096340A (en) *	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6174548B1 (en)	1998-08-28	2001-01-16	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6558700B1 (en)	1998-04-17	2003-05-06	Taisho Pharmaceutical Co., Ltd.	Multiple-unit sustained release tablets
EP1121103B1 (de) *	1998-05-18	2006-12-20	Takeda Pharmaceutical Company Limited	Im munde zerfallende tablette enthaltend ein benzimidazole
CN1149077C (zh) *	1998-07-28	2004-05-12	武田药品工业株式会社	快速崩解固体制剂
US6733778B1 (en)	1999-08-27	2004-05-11	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6544556B1 (en)	2000-09-11	2003-04-08	Andrx Corporation	Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
CA2517005A1 (en) *	2003-02-20	2004-09-02	Santarus, Inc.	A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2004074285A1 (en) *	2003-02-24	2004-09-02	Mitsubishi Pharma Corporation	The enantiomer of tenatoprazole and the use thereof in therapy
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7670624B2 (en) *	2004-01-29	2010-03-02	Astella Pharma Inc.	Gastrointestinal-specific multiple drug release system
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en)	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TR201816133T4 (tr)	2006-04-04	2018-11-21	Kg Acquisition Llc	Bi̇r anti̇platelet ajan ve bi̇r asi̇t i̇nhi̇bi̇törü i̇çeren oral dozaj formlari.
EP2026768B1 (de) *	2006-06-01	2018-02-28	Dexcel Pharma Technologies Ltd.	Pharmazeutische formulierung auf mehreren einheiten
JP5041774B2 (ja) *	2006-09-22	2012-10-03	日本ケミファ株式会社	メサラジンを有効成分として含有する徐放性錠剤
JP4329947B1 (ja) *	2009-01-20	2009-09-09	ライオン株式会社	内服用錠剤
CN102198131A (zh) *	2010-03-24	2011-09-28	济南瑞安药业发展有限公司	一种含有奥美拉唑的新的复方制剂
EA201390814A1 (ru) *	2010-12-03	2013-11-29	Такеда Фармасьютикал Компани Лимитед	Перорально распадающаяся таблетка
EP3288556A4 (de)	2015-04-29	2018-09-19	Dexcel Pharma Technologies Ltd.	Oral zerfallende zusammensetzungen
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB971486A (en) *	1960-04-01	1964-09-30	Rech S Pharma Et Scient	Therapeutic compositions comprising aspirin and polysiloxanes
US4874614A (en) *	1985-03-25	1989-10-17	Abbott Laboratories	Pharmaceutical tableting method
CA1259924A (en) *	1985-03-25	1989-09-26	Wallace E. Becker	Pharmaceutical tableting method
CA1327010C (en) *	1986-02-13	1994-02-15	Tadashi Makino	Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
JPH0780754B2 (ja) *	1986-08-06	1995-08-30	エーザイ株式会社	多顆粒型持続性錠剤
JP2514078B2 (ja) *	1988-08-22	1996-07-10	エスエス製薬株式会社	圧縮成型製剤
JP2781442B2 (ja) *	1990-02-19	1998-07-30	旭化成工業株式会社	顆粒含有錠剤
JP2856485B2 (ja) *	1990-03-07	1999-02-10	旭化成工業株式会社	顆粒含有錠

1994
- 1994-10-06 DK DK94929012T patent/DK0723777T3/da active
- 1994-10-06 EP EP94929012A patent/EP0723777B1/de not_active Expired - Lifetime
- 1994-10-06 CA CA002173506A patent/CA2173506C/en not_active Expired - Lifetime
- 1994-10-06 AT AT94929012T patent/ATE219931T1/de active
- 1994-10-06 JP JP51158095A patent/JP3710473B2/ja not_active Expired - Lifetime
- 1994-10-06 DE DE69430921T patent/DE69430921T2/de not_active Expired - Lifetime
- 1994-10-06 AU AU78222/94A patent/AU683092B2/en not_active Expired
- 1994-10-06 PT PT94929012T patent/PT723777E/pt unknown
- 1994-10-06 US US08/624,510 patent/US5798120A/en not_active Expired - Lifetime
- 1994-10-06 ES ES94929012T patent/ES2179079T3/es not_active Expired - Lifetime
- 1994-10-06 WO PCT/JP1994/001675 patent/WO1995010264A1/ja active IP Right Grant
- 1994-10-06 KR KR1019960701804A patent/KR100353384B1/ko not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US5798120A (en)	1998-08-25
KR960704531A (ko)	1996-10-09
CA2173506A1 (en)	1995-04-20
CA2173506C (en)	2006-05-09
KR100353384B1 (ko)	2002-12-28
DE69430921D1 (de)	2002-08-08
ES2179079T3 (es)	2003-01-16
WO1995010264A1 (fr)	1995-04-20
PT723777E (pt)	2002-11-29
JP3710473B2 (ja)	2005-10-26
EP0723777B1 (de)	2002-07-03
DE69430921T2 (de)	2003-02-13
AU7822294A (en)	1995-05-04
EP0723777A4 (de)	1997-06-25
EP0723777A1 (de)	1996-07-31
ATE219931T1 (de)	2002-07-15
AU683092B2 (en)	1997-10-30

Publication	Publication Date	Title
DK0723777T3 (da)	2002-10-28	Tablet indeholdende enteriske granuler
US3074852A (en)	1963-01-22	Pharmaceuticals with delayed release
ATE52688T1 (de)	1990-06-15	Pellet-zubereitung.
KR910004180A (ko)	1991-03-28	저작성 약제학적 정제를 제조하기 위한 회전과립화 공정 및 맛을 은폐하기 위한 피복공정
EP1435240A3 (de)	2009-08-12	Feste orale Dosierungsformen enthaltend eine Kombination von Glibenclamid und Metformin
IL72664A0 (en)	1984-11-30	Controlled release pharmaceutical compositions comprising cross-linked,porous polymers
KR890016968A (ko)	1989-12-14	약제 흡착물
JPH0155244B2 (de)	1989-11-22
EP0103387A3 (de)	1984-12-12	Langwirkende Matrix-Tabletten-Formulierungen
IE821861L (en)	1983-02-05	Pharmaceutical compositions
NO865195L (no)	1987-12-28	Fremgangsmte for fremstilling av et retardpreparat av ibuprofen.
RU95107880A (ru)	1997-11-10	Твердая фармацевтическая форма
ATE238784T1 (de)	2003-05-15	Granulat mit hohem gehalt an l-carnitine oder einem alkanoyl l-carnitine, insbesondere für die herstellung von direktverpressten tabletten
JPS5533425A (en)	1980-03-08	Production of gradually releasing preparation
RU97105420A (ru)	1999-05-10	Твердая лекарственная форма на основе сульфаметоксазола и триметоприма
JPS52138583A (en)	1977-11-18	Preparation of vinyl chloride polymers
EP0106028A3 (de)	1985-10-30	Diuretische/blutdrucksenkende Zusammensetzungen und Verfahren zu ihrer Herstellung
RU96123569A (ru)	1999-01-27	Лекарственный препарат
JP2001187738A (ja)	2001-07-10	アスピリン含有製剤製品
RU95121646A (ru)	1998-02-10	Сшитая амилоза как связующее вещество/агент, вызывающий дезинтеграцию, в таблетках
KR970014764A (ko)	1997-04-28	케토프로펜을 함유하는 제약학적 혼합물 제제
US20060134193A1 (en)	2006-06-22	Method to improve pharmaceutical tablets having a matrix of cellulose ether
JPS5282993A (en)	1977-07-11	Preparation of block copolymers